Search Results
196 results
Your search is now limited to «Amgen» expert search.
ENDPOINTS 03/20/2019 10:00
DMC clears phIII testing of Cytokinetics’ Amgen-partnered heart drug.
More from ENDPOINTS:
3BL Media 03/19/2019 06:35
The openness of Amgen’s executive management to opinions and new ideas of junior staff speaks volumes about the company’s culture.
More from 3BL Media:
FiercePharmaManufacturing 03/17/2019 20:42
Amgen taps comedian Jay Leno for 'cholesterol 911' awareness push.
More from FiercePharmaManufacturing: 03/15/2019 16:44
THOUSAND OAKS, Calif., March 15, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced plans to conduct VESALIUS-CV, a multinational clinical outcomes study for Repatha® (evolocumab) which will involve at least 13,000 patients worldwide at high risk of experiencing a first cardiovascular (CV) event, despite optimized treatment with lipid-lowering therapy.1 The study will be the first to investigate long-term outcomes in this population with Repatha for a minimum of four years.1 Conducted in collaboration with the Brigham and Women's Hospital Thrombolysis in Myocardial Infarction (TIMI) Study Group, patient enrollment for VESALIUS-CV is due to begin in the second quarter of 2019.
More from
Amgen News Release 03/15/2019 16:00
Through its own research and development efforts, as well as partnerships, Amgen is building a robust cardiovascular portfolio consisting of several approved and investigational molecules in an effort to address a number of today's important unmet patient needs, such as high cholesterol and heart failure.
More from Amgen News Release:
Seeking Alpha 03/12/2019 14:30
David Meline So, yeah, I mean, it starts with the priorities for capital allocation and I think everybody is quite clear in the sector that they would rather see Amgen investing its resources into incremental and breakthrough innovation.
More from Seeking Alpha: 03/11/2019 09:45
On this front, Amgen has a trailing twelve months PE ratio of 12.6, as you can see in the chart below: This level actually compares favorably with the market at large, as the PE for the S&P 500 stands ...
More from
PR Newswire 02/28/2019 08:34
The 2019 Amgen Tour of California announced Morro Bay will host the Stage 4 Finish of the men's race on May 15, 2019 following the scenic route the Amgen Tour took in 2017, when Peter Sagan won the sprint finish ...
More from PR Newswire:
World Pharma News 02/27/2019 06:00
This verdict follows a previous trial in March 2016 where Sanofi and Regeneron admitted infringement of Amgen's patents and where a prior jury also upheld the validity of Amgen's patents.
More from World Pharma News:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications